Flagship explainer
What drives RenovoRx, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$11.2M | FY2025 |
| |
| Income before tax | −$11.2M | FY2025 |
|
| Operating income | −$12.5M | FY2025 |
|
| $1.1M | FY2025 |
| |
| Ending assets | $8.1M | FY2025 |
|
| Beginning assets | $8.1M | FY2024 |
|
| $5.4M | FY2025 |
| |
| $4.5M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-131928